Back to 
UBS Group AG
UBS Group AG
GENB1 quarters
Position history for UBS Group AG's holdings in GENERATE BIOMEDICINES INC
UBS Group AG holds 356,704 shares of GENB (GENERATE BIOMEDICINES INC), worth $4.5M as of 2026-Q1. This is a new position. GENB represents 0.0% of UBS Group AG's portfolio.
Current Value
$4.5M
Current Shares
356,704
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of GENB: FMR LLC, Capital World Investors, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP